Associations between E-Cigarette type, frequency of use, and quitting smoking: Findings from a longitudinal online panel survey in Great Britain

Nicotine and Tobacco Research

Volumn 17, Issue 10, 2015, Pages 1187-1194

  Hitchman, Sara C ^a,b   Brose, Leonie S ^a,b   Brown, Jamie ^c   Robson, Debbie ^a,b   McNeill, Ann ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UK CENTRE FOR TOBACCO AND ALCOHOL STUDIES   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BEHAVIOR; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; ELECTRONIC CIGARETTE; ELECTRONIC CIGARETTE CIGALIKE; ELECTRONIC CIGARETTE TANK; FEMALE; FOLLOW UP; FREQUENCY OF USE; HEALTH SURVEY; HUMAN; LONGITUDINAL STUDY; LOWEST INCOME GROUP; MALE; MIDDLE AGED; MOTIVATION TO STOP SMOKING; ONLINE SYSTEM; PARAMETERS; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SMOKING CESSATION; SMOKING HABIT; STRENGTH OF URGES TO SMOKE; UNITED KINGDOM; YOUNG ADULT; ADOLESCENT; EPIDEMIOLOGY; PREVENTION AND CONTROL; PROCEDURES; SMOKING; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; TOBACCO DEPENDENCE; UTILIZATION;

ADOLESCENT; ADULT; ELECTRONIC CIGARETTES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SMOKING; SMOKING CESSATION; SOCIOECONOMIC FACTORS; TOBACCO USE DISORDER; UNITED KINGDOM; YOUNG ADULT;

EID: 84931077209     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv078     Document Type: Article

References (45)

1. Action on Smoking and Health. Factsheet: Use of electronic cigarettes in Great Britain. 2014. www.ash.org.uk/files/documents/ASH_891.pdf. Accessed December 1, 2014.
2. Etter J-F. Electronic cigarettes: a survey of users. BMC Public Health. 2010;10:231. doi:10.1186/1471-2458-10-231.
3. Goniewicz ML, Hajek P, McRobbie H. Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction. 2014;109(3):500-507. doi:10.1111/add.12410.
4. Hitchman SC, McNeill A, Brose LS. Electronic cigarettes: time for an accurate and evidence-based debate. Addiction. 2014;109(6):867-868. doi:10.1111/add.12550.
5. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl). 2014;231(2):401-407. doi:10.1007/s00213-013-3249-8.
6. Robinson D. Japan Tobacco joins rivals in e-cigarette market with E-Lites buy. Financial Times. June 11, 2014. www.ft.com/cms/s/0/28e13462-f179-11e3-9161-00144feabdc0.html#axzz3GCmn1cDn. Accessed June 30, 2014.
7. blu. 2014. www.blucigs.co.uk/?country=GB. Accessed December 1, 2014.
8. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res. 2013;15(1):267-270. doi:10.1093/ntr/ntr316.
9. Etter J-F. Levels of saliva cotinine in electronic cigarette users. Addiction. 2014;109(5):825-829. doi:10.1111/add.12475.
10. Etter J-F, Bullen C. Saliva cotinine levels in users of electronic cigarettes. Eur Respir J. 2011;38(5):1219-1220. doi:10.1183/09031936.00066011.
11. Shihadeh AL, Eissenberg T. Electronic cigarette effectiveness and abuse liability: predicting and regulating "nicotine flux." Nicotine Tob Res. 2014;17(2):158-166. doi:10.1093/ntr/ntu175.
12. Eissenberg T, Shihadeh AL. Nicotine flux: a potentially important tool for regulating electronic cigarettes. Nicotine Tob Res. 2015;17(2):165-167. http:// ntr.oxfordjournals.org/content/early/2014/10/24/ntr.ntu208.short. Accessed November 7, 2014.
13. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res. 2013;15(1):158-166. doi:10.1093/ntr/nts103.
14. Schripp T, Markewitz D, Uhde E, Salthammer T. Does e-cigarette consumption cause passive vaping? Indoor Air. 2013;23(1):25-31. doi:10.1111/j.1600-0668.2012.00792.x.
15. Cheng T. Chemical evaluation of electronic cigarettes. Tob Control. 2014;23(suppl 2):ii11-17. doi:10.1136/tobaccocontrol-2013-051482.
16. Schroeder MJ, Hoffman AC. Electronic cigarettes and nicotine clinical pharmacology. Tob Control. 2014;23(suppl 2):ii30-35. doi:10.1136/ tobaccocontrol-2013-051469.
17. Spindle TR, Breland AB, Karaoghlanian NV, Shihadeh AL, Eissenberg T. Preliminary results of an examination of electronic cigarette user puff topography: the effect of a mouthpiece-based topography measurement device on plasma nicotine and subjective effects. Nicotine Tob Res. 2015;17(2):142-149. doi:10.1093/ntr/ntu186.
18. Talih S, Balhas Z, Eissenberg T, et al. Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield: measurements and model predictions. Nicotine Tob Res. 2015;17(2):150-157. doi:10.1093/ntr/ntu174.
19. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133-139. doi:10.1136/tobaccocontrol-2012-050859.
20. Kosmider L, Sobczak A, Fik M, et al. Carbonyl compounds in electronic cigarette vapors-effects of nicotine solvent and battery output voltage. Nicotine Tob Res. 2014;16(10):1319-1326. doi:10.1093/ntr/ntu078.
21. Farsalinos KE. Verified: formaldehyde levels found in the NEJM study were associated with dry puff conditions. An update. Ecigarette Res. 2015. www.ecigarette-research.com/web/index.php/2013-04-07-09-50-07/2015/192-form-ver. Accessed March 23, 2015.
22. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11(11):CD000146. doi:10.1002/14651858.CD000146.pub4.
23. Farsalinos KE, Spyrou A, Tsimopoulou K, Stefopoulos C, Romagna G, Voudris V. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep. 2014;4:4133. doi:10.1038/srep04133.
24. Dawkins L, Kimber C, Puwanesarasa Y, Soar K. First versus second generation electronic cigarettes: predictors of choice and effects on urge to smoke and withdrawal symptoms. Addiction. 2015;110(4):669-677. doi:10.1111/add.12807.
25. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int J Environ Res Public Health. 2014;11(4):4356-4373. doi:10.3390/ijerph110404356.
26. Adkison SE, O'Connor RJ, Bansal-Travers M, et al. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med. 2013;44(3):207-215. doi:10.1016/j.amepre.2012.10.018.
27. Grana RA, Popova L, Ling P. A longitudinal analysis of electronic cigarette use and smoking cessation. JAMA Intern Med. 2014;174(5):812-814. doi:10.1001/jamainternmed.2014.187.
28. Etter J-F, Bullen C. A longitudinal study of electronic cigarette users. Addict Behav. 2014;39(2):491-494. doi:10.1016/j.addbeh.2013.10.028.
29. Brose LS, Hitchman SC, Brown J, West R, McNeill A. Is use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? Addiction. 2015. In Press.
30. Biener L, Hargraves J. A longitudinal study of electronic cigarette use in a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res. 2015;17(2):127-133.
31. Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes whenused to aid smoking cessation: a cross-sectional population study. Addiction. 2014;109(9):1531-1540. doi:10.1111/add.12623.
32. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382(9905):1629-1637. doi:10.1016/S0140-6736(13)61842-5.
33. Caponnetto P, Campagna D, Cibella F, et al. Efficiency and safety of an electronic cigarette (eclat) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8(6):e66317. doi:10.1371/journal.pone.0066317.
34. Brown J, West R, Beard E, Michie S, Shahab L, McNeill A. Prevalence and characteristics of e-cigarette users in Great Britain: findings from a general population survey of smokers. Addict Behav. 2014;39(6):1120-1125. doi:10.1016/j.addbeh.2014.03.009.
35. West R, Brown J. Monthly tracking of key performance indicators-STS120720. 2014. www.smokinginengland.info/latest-statistics/.
36. Fidler JA, Shahab L, West R. Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerström Test for Nicotine Dependence and its components. Addiction. 2011;106(3):631-638. doi:10.1111/j.1360-0443.2010.03226.x.
37. Kotz D, Brown J, West R. Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking. Drug Alcohol Depend. 2013;128(1-2):15-19. doi:10.1016/j. drugalcdep.2012.07.012.
38. Action on Smoking and Health Scotland. ASH Scotland E-cigarettes Briefing. 2014. www.ashscotland.org.uk/media/6093/E-cigarettesbriefing.pdf.
39. Shiffman S. Use of more nicotine lozenges leads to better success in quitting smoking. Addiction. 2007;102(5):809-814. doi:10.1111/j.1360-0443.2007.01791.x.
40. Shiffman S, Sweeney CT, Ferguson SG, Sembower MA, Gitchell JG. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebocontrolled clinical trial simulating over-the-counter use in adult smokers. Clin Ther. 2008;30(10):1852-1858. doi:10.1016/S0149-2918(08)00309-3.
41. Kotz D, West R. Explaining the social gradient in smoking cessation: it's not in the trying, but in the succeeding. Tob Control. 2009;18(1):43-46. doi:10.1136/tc.2008.025981.
42. Vangeli E, Stapleton J, Smit ES, Borland R, West R. Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction. 2011;106(12):2110-2121. doi:10.1111/j.1360-0443.2011.03565.x.
43. Dillard J III. Comment on the Food and Drug Administration (FDA) Proposed Rule: Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Regulations on the Sale and Distribut. FDA-2014-N-0189-79881. 2014. www.regulations.gov/#!documentDetail;D=FDA-2014-N-0189-79881. Accessed March 18, 2015.
44. South London and Maudsley NHS Foundation Trust. South London and Maudsley NHS Foundation Trust: Smokefree-Frequently Asked Questions. 2014. www.slam.nhs.uk/our-services/smokefree/smokefreefrequently- asked-questions. Accessed December 1, 2014.
45. RAI. Comment on the Food and Drug Administration (FDA) Proposed Rule:Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Regulations on the Sale and Distribut. FDA-2014-N-0189-76048. 2014. www.regulations.gov/#!documentDetail;D=FDA-2014-N-0189-76048. Accessed March 18, 2015.